House Oversight Panel Chairman Renews Request for Documents From Mylan, Teva Pharmaceutical and Heritage Pharmaceuticals on Generic Drug Price Increases[ Says Panel is Probing Mylan, Teva and Heritage's Apparent Coordinated Obstruction of Drug Pricing Investigation